BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16246312)

  • 21. Expression patterns of the organic cation/carnitine transporter family in adult murine brain.
    Lamhonwah AM; Hawkins CE; Tam C; Wong J; Mai L; Tein I
    Brain Dev; 2008 Jan; 30(1):31-42. PubMed ID: 17576045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
    Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
    J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.
    Elimrani I; Lahjouji K; Seidman E; Roy MJ; Mitchell GA; Qureshi I
    Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G863-71. PubMed ID: 12684216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).
    Urban TJ; Yang C; Lagpacan LL; Brown C; Castro RA; Taylor TR; Huang CC; Stryke D; Johns SJ; Kawamoto M; Carlson EJ; Ferrin TE; Burchard EG; Giacomini KM
    Pharmacogenet Genomics; 2007 Sep; 17(9):773-82. PubMed ID: 17700366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.
    Kato Y; Kubo Y; Iwata D; Kato S; Sudo T; Sugiura T; Kagaya T; Wakayama T; Hirayama A; Sugimoto M; Sugihara K; Kaneko S; Soga T; Asano M; Tomita M; Matsui T; Wada M; Tsuji A
    Pharm Res; 2010 May; 27(5):832-40. PubMed ID: 20224991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
    Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A
    J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and functional characterization of organic cation/carnitine transporter family in mice.
    Tamai I; Ohashi R; Nezu JI; Sai Y; Kobayashi D; Oku A; Shimane M; Tsuji A
    J Biol Chem; 2000 Dec; 275(51):40064-72. PubMed ID: 11010964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas.
    Toracchio S; El-Zimaity HM; Urmacher C; Katz S; Graham DY
    Scand J Gastroenterol; 2008; 43(9):1108-11. PubMed ID: 18609156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma carnitine ester profiles in Crohn's disease and ulcerative colitis patients with different IGR2230a_1 genotypes.
    Talián G; Lakner L; Bene J; Komlósi K; Horváth K; Gasztonyi B; Miheller P; Figler M; Mózsik G; Tulassay Z; Melegh B
    Int J Immunogenet; 2009 Dec; 36(6):329-35. PubMed ID: 19735486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of paraffin sections of Crohn's disease for Mycobacterium paratuberculosis using polymerase chain reaction.
    Frank TS; Cook SM
    Mod Pathol; 1996 Jan; 9(1):32-5. PubMed ID: 8821953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
    Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
    J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evidence for Mycobacterium paratuberculosis in Crohn's disease.
    Behr MA; Kapur V
    Curr Opin Gastroenterol; 2008 Jan; 24(1):17-21. PubMed ID: 18043227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines.
    Maeda T; Hirayama M; Kobayashi D; Miyazawa K; Tamai I
    Drug Metab Dispos; 2007 Mar; 35(3):394-401. PubMed ID: 17142562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.
    Sekine T; Kusuhara H; Utsunomiya-Tate N; Tsuda M; Sugiyama Y; Kanai Y; Endou H
    Biochem Biophys Res Commun; 1998 Oct; 251(2):586-91. PubMed ID: 9792817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
    Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
    Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
    Wang Y; Kelly MA; Cowan TM; Longo N
    Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic agents in inflammatory bowel diseases.
    Pineton de Chambrun G; Colombel JF; Poulain D; Darfeuille-Michaud A
    Curr Opin Gastroenterol; 2008 Jul; 24(4):440-7. PubMed ID: 18622157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.